Navigation Links
Emergent and DiFusion Form Strategic Partnership to Take CleanFuze™ Antimicrobial Implants to Market
Date:7/31/2013

Austin, TX (PRWEB) July 31, 2013

Emergent Technologies, Inc., a leading innovation solutions company, and DiFusion Technologies, Inc., a pioneering orthobiologics company, announced today a strategic partnership in which Emergent will assist DiFusion in the launch of its proprietary suite of CleanFuze antimicrobial orthobiologic implants.

CleanFuze implants use DiFusion’s core technology, a novel biomaterial that resists infection and forms a direct and lasting connection with bone. This material uses Metallic Ions as Therapeutic Agents (MITA’s) to effect cellular signaling and both upstream and downstream cellular metabolic processes.

According the Centers for Disease Control and Prevention, hospital infections, including surgical site infections, are the fourth largest killer in the U.S., claiming more U.S. lives than AIDS, breast cancer and traffic accidents combined.

“DiFusion’s proven biofilm inhibition technology and strong patent position are a good fit for our Partner Solutions Model,” said Thomas Harlan, Chairman and CEO of Emergent Technologies. “Utilizing our model will help DiFusion accelerate successful market acceptance and deployment of its CleanFuze technology.”

Derrick Johns, DiFusion Founder and CEO commented, “We look forward to working with Emergent and leveraging the experience and expertise the company has developed over many years of successful technology commercialization and its numerous industry partnerships.”

DiFusion will launch its CleanFuze Xiphos™ spinal implant products in the European Union later this year and is actively seeking strategic distribution partners through its alliance with Emergent. Interested parties should contact Kris Looney at klooney(at)emergenttechnologies(dot)com.

“We are beginning to see stronger than average premarket demand in Europe for the CleanFuze Xiphos product,” said Johns, “and expect this to continue as we expand the CleanFuze platform to include antimicrobial wound care, scaffold carriers, bone growth and tissue regeneration.”

About Emergent Technologies, Inc.
Headquartered in Austin, Texas, Emergent Technologies, Inc. (Emergent) utilizes its innovation-based, partner driven model to identify, manage, develop and bring to market game-changing scientific discoveries. Emergent's diverse business and technical team along with its unique innovation process of transforming scientific breakthroughs into technology platforms with multiple applications, maximizes the value of promising ideas and underutilized intellectual properties without the risk associated with commercial development. Emergent applies its experience and expertise to provide investors, entrepreneurs, and industry partners access to innovative solutions to advance initiatives and protect and grow core businesses with novel, differentiating technology. For more information, visit the Emergent website http://www.emergenttechnologies.com.

About DiFusion Technologies, Inc.
Founded in 2008 in Austin, Texas, DiFusion Technologies, Inc. is a medical device company focused on reducing the rising incidence of surgical site infections in orthopedic and spine surgery through the development of a suite of patented antimicrobial orthobiologic polymeric implants. Initially focusing on the multi-billion dollar spinal implant market, the company has developed a technology with applicability across a variety of orthopedic segments using well characterized implants with benefits for the patient, surgeon, hospital and payer. For more information about DiFusion Technologies, visit http://www.difusiontech.com

Media Contact: Derrick Johns – djohns(at)difusiontech(dot)com

Read the full story at http://www.prweb.com/releases/2013/7/prweb10978531.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Emergent Technologies and Caisson Biotech Form Strategic Alliance with Local Health Care Providers to Improve Delivery and Performance of a Therapeutic Drug
2. Eckert & Ziegler Vitalea Science and Korea-based BioCore Bring Human Microdosing to Korea to Address the Needs of the Emergent Pharmaceutical Industry
3. GlycoVaxyn AG secures CHF 5.1 million Strategic Translation Award from the Wellcome Trust to finance clinical development of Shigella vaccine
4. DuPont Realigns Leadership Team to Accelerate Integrated Science Execution, Explores Strategic Alternatives for Performance Chemicals
5. Pittsburgh Life Sciences Greenhouse Makes Strategic Adjustment To Put Laser Focus On 2013 Goals
6. Alpha Source, Inc. Hires Strategic Sourcing Manager
7. BioLife Solutions Announces Strategic Partnership with HemaCare
8. Paul Knittle Joins Wireless Analytics as Director of Strategic Accounts
9. Inflamax Research Inc. Enters Strategic Partnership with Northern Air Environmental Technologies Inc.
10. Elsevier Signs Strategic Collaboration Agreement with Peoples Medical Publishing House, China
11. VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)...  Liquid Biotech USA , ... Sponsored Research Agreement with The University of Pennsylvania ... cancer patients.  The funding will be used to ... clinical outcomes in cancer patients undergoing a variety ... employed to support the design of a therapeutic, ...
(Date:6/24/2016)...  Regular discussions on a range of subjects including policies, ... entities said Poloz. Speaking at a lecture to ... he pointed to the country,s inflation target, which is set ... "In certain areas there needs ... economic goals, why not sit down and address strategy together?" ...
(Date:6/24/2016)... ... , ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension ... are higher end machines that use the more unconventional z-dimension of 20mm. Z-dimension ... bottom of the cuvette holder. , FireflySci has developed several Agilent flow cell ...
(Date:6/23/2016)... WA (PRWEB) , ... June 23, 2016 , ... ... announces the release of its second eBook, “Clinical Trials Patient Recruitment and Retention ... recruitment and retention in this eBook by providing practical tips, tools, and strategies ...
Breaking Biology Technology:
(Date:6/22/2016)... 22, 2016   Acuant , the ... solutions, has partnered with RightCrowd ® ... Visitor Management, Self-Service Kiosks and Continuous Workforce ... add functional enhancements to existing physical access ... venues with an automated ID verification and ...
(Date:6/15/2016)... 2016 Transparency Market Research ... Market by Application Market - Global Industry Analysis Size Share ... the report, the  global gesture recognition market  was ... is estimated to grow at a CAGR of ... Increasing application of gesture recognition technology ...
(Date:6/2/2016)... The Department of Transport Management (DOTM) ... million US Dollar project, for the , Supply ... Enrolment, and IT Infrastructure , to ... implementation of Identity Management Solutions. Numerous renowned international vendors participated ... was selected for the most compliant and innovative ...
Breaking Biology News(10 mins):